Jens Peter Andersen

Prof. Jens Peter Andersen

orcid

Research Focus & Metrics

Academic Career Length

50Years (1977-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2007 in Nature
Verified
Journal Article
Closed access
PDF file
JMJ. Preben Morth
J. Preben Morth
BPBjørn P. Pedersen
Bjørn P. Pedersen
MTMads Schak Toustrup-Jensen
Mads Schak Toustrup-Jensen
TSThomas L.-M. Sørensen
Thomas L.-M. Sørensen
JPJanne Petersen
Janne Petersen
PNPoul Nissen
Poul Nissen

22 December 2010 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
JMJ. Preben Morth
J. Preben Morth
BPBjørn P. Pedersen
Bjørn P. Pedersen
MBMorten J. Buch-Pedersen
Morten J. Buch-Pedersen
JAJens Peter Andersen
Jens Peter Andersen
BVBente Vilsen
Bente Vilsen
PNPoul Nissen
Poul Nissen

8 July 2016 in Frontiers in Physiology
Verified
Journal Article
Open access
JAJens Peter Andersen
Jens Peter Andersen
AVAnna L. Vestergaard
Anna L. Vestergaard
SMStine A. Mikkelsen
Stine A. Mikkelsen
LMLouise S. Mogensen
Louise S. Mogensen
MCMadhavan Chalat
Madhavan Chalat
RMRobert Molday
Robert Molday
P4-ATPases comprise a family of P-type ATPases that actively transport or flip phospholipids across cell membranes. This generates and maintains membrane lipid asymmetry, a property essential for a wide variety of cellular processes such as vesicle budding and trafficking, cell signaling, blood coagulation, apoptosis, bile and cholesterol homeostasis, and neuronal cell survival. Some P4-ATPases transport phosphatidylserine and phosphatidylethanolamine across the plasma membrane or intracellular membranes whereas other P4-ATPases are specific for phosphatidylcholine. The importance of P4-ATPases is highlighted by the finding that genetic defects in two P4-ATPases ATP8A2 and ATP8B1 are associated with severe human disorders. Recent studies have provided insight into how P4-ATPases translocate phospholipids across membranes. P4-ATPases form a phosphorylated intermediate at the aspartate of the P-type ATPase signature sequence, and dephosphorylation is activated by the lipid substrate being flipped from the exoplasmic to the cytoplasmic leaflet similar to the activation of dephosphorylation of Na+/K+-ATPase by exoplasmic K+. How the phospholipid is translocated can be understood in terms of a peripheral hydrophobic gate pathway between transmembrane helices M1, M3, M4, and M6. This pathway, which partially overlaps with the suggested pathway for migration of Ca2+ in the opposite direction in the Ca2+-ATPase, is wider than the latter, thereby accommodating the phospholipid head group. The head group is propelled along against its concentration gradient with the hydrocarbon chains projecting out into the lipid phase by movement of an isoleucine located at the position corresponding to an ion binding glutamate in the Ca2+- and Na+/K+-ATPases. Hence, the P4-ATPase mechanism is quite similar to the mechanism of these ion pumps, where the glutamate translocates the ions by moving like a pump rod. The accessory subunit CDC50 may be located in close association with the exoplasmic entrance of the suggested pathway, and possibly promotes the binding of the lipid substrate. This review focuses on properties of mammalian and yeast P4-ATPases for which most mechanistic insight is available. However, the structure, function and enigmas associated with mammalian and yeast P4-ATPases most likely extend to P4-ATPases of plants and other organisms.

1 July 1988 in The Journal of Membrane Biology
Verified
Journal Article
Closed access
PDF file
PJPeter Leth Jørgensen
Peter Leth Jørgensen
JAJens Peter Andersen
Jens Peter Andersen

1 April 2009 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
LYLaure Yatime
Laure Yatime
MBMorten J. Buch-Pedersen
Morten J. Buch-Pedersen
MMMaria Musgaard
Maria Musgaard
JMJ. Preben Morth
J. Preben Morth
AWAnne-Marie Lund Winther
Anne-Marie Lund Winther
NFNatalya U. Fedosova
Natalya U. Fedosova

1 November 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
LDLeonard Dode
Leonard Dode
JAJens Peter Andersen
Jens Peter Andersen
NLNatalie Leslie
Natalie Leslie
JDJittima Dhitavat
Jittima Dhitavat
BVBente Vilsen
Bente Vilsen
AHAlain HOVNANIAN
Alain HOVNANIAN
Steady-state and rapid kinetic studies were conducted to functionally characterize the overall and partial reactions of the Ca2+ transport cycle mediated by the human sarco(endo)plasmic reticulum Ca2+-ATPase 2 (SERCA2) isoforms, SERCA2a and SERCA2b, and 10 Darier disease (DD) mutants upon heterologous expression in HEK-293 cells. SERCA2b displayed a 10-fold decrease in the rate of Ca2+ dissociation from E1Ca2 relative to SERCA2a (i.e. SERCA2b enzyme manifests true high affinity at cytosolic Ca2+ sites) and a lower rate of dephosphorylation. These fundamental kinetic differences explain the increased apparent affinity for activation by cytosolic Ca2+ and the reduced catalytic turnover rate in SERCA2b. Relative to SERCA1a, both SERCA2 isoforms displayed a 2-fold decrease of the rate of E2 to E1Ca2 transition. Furthermore, seven DD mutants were expressed at similar levels as wild type. The expression level was 2-fold reduced for Gly23 → Glu and Ser920 → Tyr and 10-fold reduced for Gly749 → Arg. Uncoupling between Ca2+ translocation and ATP hydrolysis and/or changes in the rates of partial reactions account for lack of function for 7 of 10 mutants: Gly23 → Glu (uncoupling), Ser186 → Phe, Pro602 → Leu, and Asp702 → Asn (block of E1∼P(Ca2) to E2-P transition), Cys318 → Arg (uncoupling and 3-fold reduction of E2-P to E2 transition rate), and Thr357 → Lys and Gly769 → Arg (lack of phosphorylation). A 2-fold decrease in the E1∼P(Ca2) to E2-P transition rate is responsible for the 2-fold decrease in activity for Pro895 → Leu. Ser920 → Tyr is a unique DD mutant showing an enhanced molecular Ca2+ transport activity relative to wild-type SERCA2b. In this case, the disease may be a consequence of the low expression level and/or reduction of Ca2+ affinity and sensitivity to inhibition by lumenal Ca2+.